The centralized laboratory department of namru south is looking to purchase reagents as part of the projects of next-generation sequencing (NGS) that are being conducted at this command.
Ended Purchase Order Awarded Last action
- Contract number
- N3239825PA056
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $60,774
Award facts
- Contract value 100% obligated
- $60,774.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Peru
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $60,774 |
About this award
The Naval Medical Research Unit (NAMRU) South's Centralized Laboratory Department awarded a firm fixed-price purchase order valued at $60,774.07 to Illumina, Inc. for next-generation sequencing (NGS) reagents supporting ongoing genomic research initiatives at the command. The contract, awarded on September 2, 2025, with an ultimate completion date of April 30, 2026, was funded by the Bureau of Medicine and Surgery under the Department of Defense. This procurement represents a continuation of Illumina's established role as a critical reagent and equipment supplier to federal defense and civilian research agencies, with no set-aside designation applied to this award.
Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis platforms, maintains extensive federal contracting relationships across multiple agencies including the Department of Veterans Affairs, National Institutes of Health, and the U.S. Department of Agriculture. The company holds a significant $45 million indefinite delivery contract with USDA through June 2030 and has demonstrated substantial experience providing sequencing instruments, reagent kits, consumables, and bioinformatics software to support research in infectious disease, cancer diagnostics, and antimicrobial resistance studies. The NAMRU South purchase order will be performed in Peru, supporting the command's genetic research capabilities in an operational research environment.
Quick answers
Who was awarded contract N3239825PA056?
N3239825PA056 was awarded to Illumina, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 2, 2025.
How much is contract N3239825PA056 worth?
The government has obligated $60,774 on N3239825PA056.
Was contract N3239825PA056 competed?
The extent of competition for N3239825PA056 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award